{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:31:20Z","timestamp":1783161080130,"version":"3.54.6"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":1095,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jpainsymman.2019.12.001","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T04:51:40Z","timestamp":1575867100000},"page":"e6-e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-emetics"],"prefix":"10.1016","volume":"59","author":[{"given":"Sander D.","family":"Borgsteede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne A.","family":"Weersink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Geijteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herold J.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.M.","family":"Hunfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2019.12.001_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jpainsymman.2019.04.034","article-title":"Prescribing in chronic severe hepatic impairment","volume":"58","author":"Wilcock","year":"2019","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40264-017-0635-x","article-title":"Evidence-based recommendations to improve the safe use of drugs in patients with liver cirrhosis","volume":"41","author":"Weersink","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00228-013-1502-z","article-title":"Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations","volume":"69","author":"Franz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40264-018-0744-1","article-title":"Prevalence of drug prescriptions and potential safety in patients with cirrhosis: a retrospective real-world study","volume":"42","author":"Weersink","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/lt.23484","article-title":"Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study","volume":"18","author":"Bajaj","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(97)90100-4","article-title":"Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation","volume":"61","author":"Tallgren","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/MEG.0000000000000894","article-title":"Response to: improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in association with zolpidem","volume":"29","author":"Nevo","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2125.1983.tb02159.x","article-title":"Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease","volume":"16","author":"Parker","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40262-015-0288-9","article-title":"A\u00a0prediction model of drug exposure in cirrhotic patients according to child-pugh classification","volume":"54","author":"Steelandt","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpainsymman.2019.12.001_bib10","article-title":"Better drug use in advanced disease: an international Delphi study","author":"Huisman","year":"2018","journal-title":"BMJ Support Palliat\u00a0Care"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392419306797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392419306797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:26:17Z","timestamp":1760131577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392419306797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0885392419306797"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.12.001","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-emetics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.04.034","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}